🧮 NIKA Revenue Breakdown
Understanding Revenue
Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For NIKA, the trailing twelve month revenue is $156.
Why Revenue Matters
Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.
NIKA's revenue growth rate of N/A (based on log-linear regression of 0 quarters) indicates relatively flat or slightly declining sales.
Revenue vs Profitability Metrics
Free Cash Flow: $0 →
The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.
Owner Earnings: N/A →
Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.
Earnings Per Share: $N/A →
Net income per share. The bottom line result of all revenue after costs, taxes, and interest.
Net Income: $-78.1K
What remains after all expenses. Net margin shows what percentage of revenue becomes profit.
Price/Sales Ratio Analysis
NIKA's P/S ratio of 2,764,055.0x means investors pay $2,764,055.01 for every $1 of annual revenue. A P/S above 10 indicates very high growth expectations.
Gross Margin: Revenue Quality
Gross margin of N/A shows how much of NIKA's revenue remains after direct costs.
Summary: NIKA Revenue Trend
NIKA PHARMACEUTICALS, INC. (NIKA) generated $156 in trailing twelve-month revenue, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring. Gross margin: N/A. For complete financial analysis, view the full NIKA stock report on Zyberno.
Frequently Asked Questions
What is NIKA's current revenue?
NIKA PHARMACEUTICALS, INC.'s trailing twelve month (TTM) revenue is $156, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.
Is NIKA's revenue growing?
NIKA PHARMACEUTICALS, INC. (NIKA) generated $156 in trailing twelve-month revenue, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring. Gross margin: N/A.
What is NIKA's gross margin?
NIKA's gross margin is N/A.
What is NIKA's Price/Sales ratio?
NIKA's P/S ratio is 2,764,055.0x, meaning the market values the company at 2,764,055.0 times its annual revenue.
How does revenue differ from profit?
Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. NIKA's revenue is $156 with a net income of $-78.1K, showing a net profit margin of -50,080.1%.
📊 Full NIKA Stock Report →
See NIKA's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 NIKA Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 NIKA Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 NIKA Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 NIKA Earnings Surprise (SUE) →
See whether NIKA is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 NIKA Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 NIKA Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 NIKA Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 NIKA Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.